Mersana Therapeutics Inc (MRSN.OQ)
MRSN.OQ on NASDAQ Stock Exchange Global Select Market
3.80USD
17 Jan 2019
3.80USD
17 Jan 2019
Change (% chg)
-- (--)
-- (--)
Prev Close
$3.80
$3.80
Open
--
--
Day's High
--
--
Day's Low
--
--
Volume
--
--
Avg. Vol
37,017
37,017
52-wk High
$23.67
$23.67
52-wk Low
$3.39
$3.39
Revenue & Earnings Per Share
| Revenue* | Earnings Per Share** | ||
|---|---|---|---|
| FY 2018 | Sep '18 | 2.15 | -0.737 |
| Jun '18 | 4.19 | -0.538 | |
| Mar '18 | 3.06 | -0.544 | |
| FY 2017 | Dec '17 | 3.26 | -0.613 |
| Sep '17 | 6.27 | -0.340 | |
| Jun '17 | 3.73 | -0.394 | |
| Mar '17 | 4.29 | -0.356 |
*Note: Units in Millions ofU.S. Dollars
**Note: Units in U.S. Dollars
Consensus Estimates Analysis
| # of Estimates | Mean | High | Low | 1 Year Ago | |
|---|---|---|---|---|---|
| SALES (in millions) | |||||
| Quarter Ending Mar-19 | 3 | 4.69 | 5.50 | 3.56 | -- |
| Quarter Ending Jun-19 | 3 | 4.72 | 5.50 | 3.65 | -- |
| Year Ending Dec-19 | 5 | 20.58 | 27.00 | 15.00 | 25.01 |
| Earnings (per share) | |||||
| Quarter Ending Mar-19 | 4 | -0.62 | -0.49 | -0.70 | -- |
| Quarter Ending Jun-19 | 4 | -0.64 | -0.53 | -0.71 | -- |
| Year Ending Dec-19 | 6 | -2.39 | -1.91 | -2.79 | -1.91 |
Sales and Profit Figures in US Dollar (USD);
Valuation Ratios
| Company | industry | sector | ||
|---|---|---|---|---|
| P/E Ratio (TTM) | -- | 69.71 | 33.71 | |
| P/E High - Last 5 Yrs. | -- | 148.01 | 49.93 | |
| P/E Low - Last 5 Yrs. | -- | 47.79 | 24.27 | |
| Beta | -- | 1.08 | 0.90 | |
| Price to Sales (TTM) | -- | 49.51 | 6.28 | |
| Price to Book (MRQ) | -- | 10.16 | 5.27 | |
| Price to Tangible Book (MRQ) | 18.86 | 13.82 | 6.79 | |
| Price to Cash Flow (TTM) | -- | 52.80 | 24.84 | |
| % Owned Institutions | 78.13 | 3.75 | 1.69 | |
Dividends
| Company | industry | sector | ||
|---|---|---|---|---|
| Dividend Yield | -- | 0.12 | 1.40 | |
| Dividend Yield - 5 Year Avg | -- | 0.09 | 1.42 | |
| Dividend 5 Year Growth Rate | -- | 0.79 | 4.83 | |
| Payout Ratio(TTM) | -- | 7.04 | 41.08 | |
Growth Rates
| Company | industry | sector | ||
|---|---|---|---|---|
| Sales (MRQ) vs Qtr. 1 Yr. Ago | -- | 130.04 | 9.72 | |
| Sales (TTM) vs TTM 1 Yr. Ago | -- | 47.85 | 5.87 | |
| Sales - 5 Yr. Growth Rate | -- | 22.76 | 11.20 | |
| EPS (MRQ) vs Qtr. 1 Yr. Ago | -- | 75.87 | 47.26 | |
| EPS (TTM) vs TTM 1 Yr. Ago | -- | -- | -- | |
| EPS - 5 Yr. Growth Rate | -- | 12.03 | 10.82 | |
| Capital Spending - 5 Yr. Growth Rate | -- | 9.25 | 15.18 | |
Financial Strength
| Company | industry | sector | |
|---|---|---|---|
| Quick Ratio (MRQ) | -- | 2.18 | 2.26 |
| Current Ratio (MRQ) | 2.53 | 3.43 | 3.08 |
| LT Debt to Equity (MRQ) | 0.00 | 18.73 | 11.38 |
| Total Debt to Equity (MRQ) | 0.00 | 31.43 | 16.13 |
| Interest Coverage (TTM) | -- | -43.27 | 29.51 |
Profitability Ratios
| Company | industry | sector | ||
|---|---|---|---|---|
| Gross Margin (TTM) | -- | 56.29 | 53.78 | |
| Gross Margin - 5 Yr. Avg. | -- | 60.55 | 52.17 | |
| EBITD Margin (TTM) | -- | -- | -- | |
| EBITD - 5 Yr. Avg | -- | -110.00 | 12.88 | |
| Operating Margin (TTM) | -- | -184.42 | 6.20 | |
| Operating Margin - 5 Yr. Avg. | -- | -126.43 | 8.32 | |
| Pre-Tax Margin (TTM) | -- | -175.20 | 7.17 | |
| Pre-Tax Margin - 5 Yr. Avg. | -- | -132.58 | 8.62 | |
| Net Profit Margin (TTM) | -- | -181.93 | 3.30 | |
| Net Profit Margin - 5 Yr. Avg. | -- | -136.98 | 4.89 | |
| Effective Tax Rate (TTM) | -- | 21.48 | 22.88 | |
| Effective Tax Rate - 5 Yr. Avg. | -- | 15.57 | 23.39 | |
Efficiency
| Company | industry | sector | ||
|---|---|---|---|---|
| Revenue/Employee (TTM) | -- | 7,650,742 | 844,239,900 | |
| Net Income/Employee (TTM) | -- | 652,581 | 100,064,185 | |
| Receivable Turnover (TTM) | -- | 6.25 | 5.72 | |
| Inventory Turnover (TTM) | -- | 1.89 | 3.48 | |
| Asset Turnover (TTM) | -- | 0.32 | 0.93 | |
Management Effectiveness
| Company | industry | sector | ||
|---|---|---|---|---|
| Return on Assets (TTM) | -- | 6.45 | 11.08 | |
| Return on Assets - 5 Yr. Avg. | -- | 5.52 | 12.21 | |
| Return on Investment (TTM) | -- | 8.99 | 14.48 | |
| Return on Investment - 5 Yr. Avg. | -- | 6.85 | 15.88 | |
| Return on Equity (TTM) | -- | 10.13 | 15.99 | |
| Return on Equity - 5 Yr. Avg. | -- | 8.39 | 17.00 | |
| 1 Year | 3 Year | 5 Year | |
|---|---|---|---|
| Sales % | 142.99 | -- | -- |
| EPS (TTM) % | 16.61 | -- | -- |
| Dividend % | -- | -- | -- |
Note: Units in Millions of US Dollars
Performance for Mersana Therapeutics Inc
| Period | % Actual |
% vs. S&P 500 |
Rank In Industry |
Industry Rank |
|---|---|---|---|---|
| 4 Week | 6.92 | 3.23 | 99 | 99 |
| 13 Week | 42.40 | 35.47 | 99 | 95 |
| 26 Week | -- | -- | -- | 98 |
| 52 Week | -- | -- | -- | 72 |
| YTD | -- | -- | -- | 72 |
Note:: Rank is a percentile that ranges from 0 to 99, with 99 = best.
Institutional Holders
| % Shares Owned: | 78.41% |
| # of Holders: | 79 |
| Total Shares Held: | 18,178,059 |
| 3 Mo. Net Change: | -1,765,054 |
| # New Positions: | 0 |
| # Closed Positions: | 0 |
| # Increased Positions: | 1 |
| # Reduced Positions: | 8 |
| # Net Buyers: | -7 |
NYSE and AMEX quotes delayed by at least 20 minutes. NASDAQ delayed by at least 15 minutes. For a complete list of exchanges and delays, please click here.